Home > Healthcare > Biotechnology > Biotechnology R&D > Induced Pluripotent Stem Cells Production Market

Induced Pluripotent Stem Cells Production Market Share

Report ID: GMI7651
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Induced Pluripotent Stem Cells Production Market Share

The induced pluripotent stem cells production industry is characterized by diverse players competing in the industry, leveraging their research capabilities and global presence. Strategic collaborations, product innovations, and regulatory compliance further strengthen their positions. The market is characterized by ongoing technological advancements and a focus on developing safer and more effective products and services, further intensifying the competitive dynamics in the healthcare sector.

Induced Pluripotent Stem Cells Production Market Companies

The prominent players operating in the induced pluripotent stem cells production industry is as mentioned below:

Lonza
Axol Biosciences Ltd.
Evotec SE
Hitachi Ltd.
Merck KGaA
REPROCELLS, Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellsFactory III
Applied StemCells, Inc.
Creative Biolabs
Bio-Techne Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Induced pluripotent stem cells production industry size was worth USD 1.4 billion in 2023 and is anticipated to reach USD 3.4 billion by 2032 driven by the expanding field of drug discovery and development.

The consumables & kits segment held a sizable revenue share in 2022 and is expected to depict an 8.9% growth rate from 2024 to 2032 propelled by the escalating adoption of iPSC technology across various scientific disciplines, including regenerative medicine and drug discovery.

North America induced pluripotent stem cells production market accounted for 41.3% of revenue share in 2022 and is poised to exhibit notable growth through 2032 attributed to a robust infrastructure for biotechnology R&D, coupled with significant investments in healthcare and life sciences.

The leading companies engaged in the induced pluripotent stem cells production industry are Lonza, Axol Biosciences Ltd., Evotec SE, Hitachi Ltd., Merck KGaA, Thermo Fisher Scientific, Inc., Applied StemCells, Inc., Creative Biolabs, and Bio-Techne Corporation, among others.